BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19446733)

  • 1. Phosphoproteomic analysis of chemokine signaling networks.
    O'Hayre M; Salanga CL; Dorrestein PC; Handel TM
    Methods Enzymol; 2009; 460():331-46. PubMed ID: 19446733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
    O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
    PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.
    Wojcechowskyj JA; Lee JY; Seeholzer SH; Doms RW
    PLoS One; 2011; 6(9):e24918. PubMed ID: 21949786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
    Burger M; Hartmann T; Krome M; Rawluk J; Tamamura H; Fujii N; Kipps TJ; Burger JA
    Blood; 2005 Sep; 106(5):1824-30. PubMed ID: 15905192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
    Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
    Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
    Barretina J; Juncà J; Llano A; Gutiérrez A; Flores A; Blanco J; Clotet B; Esté JA
    Ann Hematol; 2003 Aug; 82(8):500-505. PubMed ID: 12783211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
    Möhle R; Failenschmid C; Bautz F; Kanz L
    Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a tandem affinity phosphoproteomic method with motif selectivity and its application in analysis of signal transduction networks.
    Herring LE; Grant KG; Blackburn K; Haugh JM; Goshe MB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():166-74. PubMed ID: 25777480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
    Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
    Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.
    Pavlasova G; Borsky M; Seda V; Cerna K; Osickova J; Doubek M; Mayer J; Calogero R; Trbusek M; Pospisilova S; Davids MS; Kipps TJ; Brown JR; Mraz M
    Blood; 2016 Sep; 128(12):1609-13. PubMed ID: 27480113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
    Teicher BA; Fricker SP
    Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zirconium(IV)-IMAC Revisited: Improved Performance and Phosphoproteome Coverage by Magnetic Microparticles for Phosphopeptide Affinity Enrichment.
    Arribas Diez I; Govender I; Naicker P; Stoychev S; Jordaan J; Jensen ON
    J Proteome Res; 2021 Jan; 20(1):453-462. PubMed ID: 33226818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
    Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
    Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.
    Puchert M; Engele J
    Cell Tissue Res; 2014 Feb; 355(2):239-53. PubMed ID: 24292718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
    Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
    Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.